Switching to olmesartan medoxomil/amlodipine vs continuing amlodipine monotherapy in Chinese patients with mild-to-moderate essential hypertension

Trial Profile

Switching to olmesartan medoxomil/amlodipine vs continuing amlodipine monotherapy in Chinese patients with mild-to-moderate essential hypertension

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Nov 2012

At a glance

  • Drugs Olmesartan medoxomil/amlodipine (Primary) ; Amlodipine
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Nov 2012 New trial record
    • 04 Oct 2012 Primary endpoint 'Seated-blood-pressure' has been met.
    • 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top